LRRK2-PD performed better than iPD patients on cognitive tests such as the congruent Stroop, Stroop interference and Verbal fluency tests (padj are < 0.001, 0.0047, 0.056 & 0.039 respectively). This evidence concerns the gene LRRK2 and Parkinson disease.